Tomás Palanques-Pastor, Juan Eduardo Megías‐Vericat, Pilar Martı́nez, José Luis López Lorenzo, Javier Cornago Navascués, Gabriela Rodríguez Macias, Isabel Cano, Montserrat Arnán Sangerman, María Belén Vidriales Vicente, Jesús Lorenzo Algarra, María Ángeles Foncillas, Pilar Herrera, Carmen Botella Prieto, Susana Vives, Ángela Figuera Álvarez, Laida Cuevas Palomares, Marta Sobas, Alejandro Gonzalo, Rebeca Cuello García, María Elena Amutio Diez, D. de Miguel Llorente, Begoña Navas Elorza, Juan Bergua, Teresa Bernal, María Carmen Mateos Rodriguez, Erik de Cabo, A Villegas, Raimundo García Boyero, Cristián Escolano Escobar, Cristina Seri Merino, Carlos Cerveró, Alicia Roldán, Lourdes Hermosín Ramos, Marta Cervera Calvo, María Telesa Olave, Paola Villafuerte Gutiérrez, Almudena de Laiglesiai, Josefina Serrano, María Josefa Najera Irazu, José Luís Piñana, Miguel Á. Sanz, Joaquín Martínez‐López, Pau Montesinos,
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces higher morbidity and mortality in hematological malignancies, but evidence in acute myeloid leukemia (AML) is scarce. A multicenter observational study was conducted to determine the clinical outcomes and assess the impact of therapeutic approaches in adult AML patients with SARS-CoV-2 infection in the first wave (March–May 2020). Overall, 108 patients were included: 51.9% with active leukemia and 70.4% under therapeutic ...
Tópico(s): Hematological disorders and diagnostics
2021 - Taylor & Francis | Leukemia & lymphoma/Leukemia and lymphoma
Pilar Martı́nez, T Palanques Pastor, Jose Luiz Lopez Lorenzo, Javier Cornago Navascués, Gabriela Rodríguez‐Macías, Isabel Cano, Montserrat Arnán Sangerman, María‐Belén Vidriales, Jesús Lorenzo Algarra, María Ángeles Foncillas, Pilar Herrera Puente, Carmen Botella, Susana Vives, Ángela Figuera Álvarez, Laida Cuevas Palomares, Marta Sobas, Alejandro Contento-Gonzalo, Rebeca Cuello, María Elena Amutio Diez, Maria Dunia De Miguel, Begoña Navas, Juan Miguel Bergua Burgués, Teresa Bernal, María Carmen Mateos Rodriguez, Erik de Cabo, A Villegas, Raimundo García‐Boyero, Cristián Escolano Escobar, Cristina Serí, Carlos Cerveró, Alicia Roldán, María Lourdes Hermosín, Marta Cervera, María T. Olave, Paola Sandra Villafuerte Gutierrez, Almudena de Laiglesia, Josefina Serrano, María Josefa Najera Irazu, José Luis Piñana Sánchez, Miguel Á. Sanz, Joaquín Martínez‐López, Pau Montesinos,
SARS-CoV-2 infection can impact survival of patients with acute myeloid leukemia (AML). International experts recommend considering delaying or stopping AML treatment, test patients who need intensive induction and s prioritizing outpatient treatment. However there is little published evidence in AML. Objective To analyze the clinical futures and outcome of SARS-CoV-2 infection in AML patients. Methods and patients Observational multicenter study between March and May 2020; 117 patients reported ...
Tópico(s): Hematological disorders and diagnostics
2020 - Elsevier BV | Blood